Frontiers in Cardiovascular Medicine

Case Report

Published on 13 Feb 2026

Highly suspected fulminant myocarditis induced by the immune checkpoint inhibitor tislelizumab: a case report with third-degree atrioventricular block and recurrent ventricular tachycardia

in Cardio-Oncology

Junru Qu
Miao Liu
Neil Johnson
Wenwen Zhang
Zhiqiang Wang
Yingyi Su
Beibei Du
Yuquan He

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2026.1726826

176 views

Systematic Review

Published on 11 Feb 2026

Risk factors for atrial fibrillation after lung cancer surgery: a meta-analysis

in Cardio-Oncology

Jingyu Zhang
Siyu Liu
Jiayao Li
Yuqian Wang
Ming Ni
Cheng Jiang
Songqun Huang
Zhifu Guo

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2026.1768794

203 views

Original Research

Accepted on 09 Feb 2026

Predicting Cardiovascular Toxicity in Anti-PD-1/PD-L1 Therapy: A Risk Factor Analysis and Model Development

in Cardio-Oncology

Zhihui Yan
Juan Wang
Jianxiu Sun
Run Zhang
Jia Liu
Lihua Cao
Ming Zhang
Jiangtao PD Dr. Yu
Helei Hou
Wenzhong Zhang

Frontiers in Cardiovascular Medicine

Review

Accepted on 09 Feb 2026

Cardiotoxicity Associated with Anticancer Therapies for Gynecological Tumors

in Cardio-Oncology

Liu Yang
Jixian Liao
Li Jing
Zanhong Wang

Frontiers in Cardiovascular Medicine

Correction

Accepted on 29 Jan 2026

Correction: Cardiac metastasis mimicking acute myocardial infarction in a patient with urachal carcinoma: a case report and diagnostic dilemma

in Cardio-Oncology

huanglie xie
ke zhang
pengyu han
chaoyang zheng

Frontiers in Cardiovascular Medicine

Brief Research Report

Published on 27 Jan 2026

Undetectable brain natriuretic peptide as a marker of ultrasound-detected hypovolemia in patients with cancer on active treatment

in Cardio-Oncology

Amy Tu Trinh Le
Raed Qarajeh
Bart Wilder
Akash Sharma
Lolita Golemi
Tochukwu Okwuosa

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2026.1606572

475 views

Case Report

Accepted on 26 Jan 2026

Case Report:Application of Multimodal Imaging in the Diagnosis and Treatment Evaluation of Primary Cardiac Lymphoma

in Cardio-Oncology

Jing Liang
Han Xing Shi

Frontiers in Cardiovascular Medicine

Case Report

Published on 16 Jan 2026

Case Report: Immune checkpoint inhibitor-associated pulmonary hypertension

in Cardio-Oncology

Shanshan Yuan
Xueqing Hu
Yunquan Zhao
Hongyan Dai

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1705102

713 views

Original Research

Published on 15 Jan 2026

A case series and literature review of immune checkpoint inhibitors-associated myocarditis (ICIM) in non-small cell lung cancer

in Cardio-Oncology

Yongzhen Sun
Yuan Liu
Yan Wang
Xiaomin Dai
Lin Shi
Jing Bi
Jing Zhang
Yuanlin Song
Jinjun Jiang
Shujing Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1615085

636 views

Review

Published on 08 Jan 2026

Cancer therapy-related cardiovascular aging: mechanisms, monitoring, and intervention strategies

in Cardio-Oncology

Xinyue Lin
Zhebin Wu
Yanfang Liu
Xiang Liao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1668623

948 views

Case Report

Published on 08 Jan 2026

Case Report: A case of heart failure recovery after non-ischemic cardiomyopathy following chimeric antigen receptor T-cell therapy

in Cardio-Oncology

G. Spears
J. C. Henson
S. Vellanki
A. Trikannad
H. Paydak

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1608404

909 views

Original Research

Published on 06 Jan 2026

Machine learning models using multimodal data accurately predict chemotherapy-induced cardiotoxicity in breast cancer

in Cardio-Oncology

Kundi Chen
Yuqiong An
Zhen Wang
Fang Nie

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1707889

934 views

Clinical Trial

Published on 02 Jan 2026

Anthracycline-induced cardiotoxicity associated with myocardial energy metabolism: mechanisms revealed through an integration of 18F-FDG PET/CT and data-independent acquisition proteomics

in Cardio-Oncology

Yining Xu
Yihan Chen
Shujie Zhang
Biyun Zhang
Yao Zhu
Haiwen Ni
Weimin Jiang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1726943

1,237 views

Case Report

Published on 18 Dec 2025

Cardiac metastasis mimicking acute myocardial infarction in a patient with urachal carcinoma: a case report and diagnostic dilemma

in Cardio-Oncology

Huanglie Xie
Ke Zhang
Pengyu Hang
Chaoyang Zheng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1672655

909 views

Study Protocol

Published on 24 Nov 2025

Investigation of Sheng Mai Yin in the treatment of anthracycline-induced frequent premature ventricular contractions in cancer patients: study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial

in Cardio-Oncology

Qiwen Yang
Chaofeng Niu
Meng Li
Tangshun Wang
Ce Wang
Longzhen Han
Lan Wei
Yayue Zhang
Dong Li
Shuhua Yi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1670053

1,172 views

Review

Published on 14 Nov 2025

NO/NOS system dysregulation as a key molecular mechanism in chemotherapy-induced cardiotoxicity: a review

in Cardio-Oncology

András Nagy
Zoltán Virág
Viktória Kiss
Denise Börzsei
Csaba Varga
Renáta Szabó

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1682471

1,475 views

Systematic Review

Published on 11 Nov 2025

Soluble suppression of tumorigenicity-2 changes during cardiotoxic cancer treatment: a systematic review and meta-analysis

in Cardio-Oncology

Luca Fazzini
Simone Angius
Nicola Campana
Luca Pascalis
Martino Deidda
Giordano Maria Pugliesi
Vincenzo Quagliariello
Nicola Maurea
Carlo Gabriele Tocchetti
Pietro Ameri

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1624023

1,195 views

Case Report

Published on 04 Nov 2025

Case Report: Diagnostic challenges and therapeutic approaches in cardiac intimal sarcoma: a rare clinical case study

in Cardio-Oncology

Chao Ma
Junyi Tang
Yin Xiao
Wenbin Tian
Tao Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1668911

1,088 views

Review

Published on 23 Oct 2025

Current strategies for prevention of cancer therapy-related cardiotoxicity: pharmacological, non-pharmacological and emerging approaches

in Cardio-Oncology

Michele Migliari
Luca Fazzini
Nicola Campana
Martino Deidda
Mariele Dessì
Christian Cadeddu Dessalvi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1668308

3,309 views

Original Research

Published on 10 Oct 2025

Analysis of risk factors for major adverse cardiac events in patients with multiple myeloma

in Cardio-Oncology

Yu Feng
Jingjing Zhou
Shilv Chen
Shuo Li
Tianlan Li
Yan Gao
Qianqian Wang
Yujie Xu
Chunxia Mao
Shanshan Liu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1633543

1,838 views

Systematic Review

Published on 22 Sep 2025

From bench to bedside: investigating SGLT2 inhibitors as a novel strategy against chemotherapy-induced cardiomyopathy

in Cardio-Oncology

Rade Jibawi Rivera
Faris Muaref
Sulaiman Paika
Abdullah Ruyyashi
Christopher S Gondi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1647747

3,003 views
1 citation

Case Report

Published on 18 Sep 2025

A case report of hepatocarcinoma-originated pericardial malignancy

in Cardio-Oncology

Bin Wu
Zhixiao Wang
Weizhe Lin
Jian Xiong
Chaoyong He

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1643805

1,648 views
1 citation

Original Research

Published on 15 Sep 2025

L-shaped association of low-density lipoprotein cholesterol with all-cause and cardiovascular mortality in cancer survivors: a population-based cohort study

in Cardio-Oncology

Bowen Hou
Yali Hu
Hairong Wang
Huang Zhang
Xingyu Gao
Ying Cui
Yilin Zhao
Jing Xie
Xiaomei Yu
Lang Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1593824

2,749 views

Original Research

Published on 12 Sep 2025

SGLT2i use is associated with reduced risks of cardiopulmonary inflammatory complications in cancer patients with diabetes: a retrospective cohort study

in Cardio-Oncology

Dan Li
Yanlin Li
Lingyu Meng
Xin Yu
Min Jiao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1657240

1,578 views

393 articles

articles

Highly suspected fulminant myocarditis induced by the immune checkpoint inhibitor tislelizumab: a case report with third-degree atrioventricular block and recurrent ventricular tachycardia

Risk factors for atrial fibrillation after lung cancer surgery: a meta-analysis

Predicting Cardiovascular Toxicity in Anti-PD-1/PD-L1 Therapy: A Risk Factor Analysis and Model Development

Cardiotoxicity Associated with Anticancer Therapies for Gynecological Tumors

Correction: Cardiac metastasis mimicking acute myocardial infarction in a patient with urachal carcinoma: a case report and diagnostic dilemma

Undetectable brain natriuretic peptide as a marker of ultrasound-detected hypovolemia in patients with cancer on active treatment

Case Report:Application of Multimodal Imaging in the Diagnosis and Treatment Evaluation of Primary Cardiac Lymphoma

Case Report: Immune checkpoint inhibitor-associated pulmonary hypertension

A case series and literature review of immune checkpoint inhibitors-associated myocarditis (ICIM) in non-small cell lung cancer

Cancer therapy-related cardiovascular aging: mechanisms, monitoring, and intervention strategies

Case Report: A case of heart failure recovery after non-ischemic cardiomyopathy following chimeric antigen receptor T-cell therapy

Machine learning models using multimodal data accurately predict chemotherapy-induced cardiotoxicity in breast cancer

Anthracycline-induced cardiotoxicity associated with myocardial energy metabolism: mechanisms revealed through an integration of 18F-FDG PET/CT and data-independent acquisition proteomics

Cardiac metastasis mimicking acute myocardial infarction in a patient with urachal carcinoma: a case report and diagnostic dilemma

Investigation of Sheng Mai Yin in the treatment of anthracycline-induced frequent premature ventricular contractions in cancer patients: study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial

NO/NOS system dysregulation as a key molecular mechanism in chemotherapy-induced cardiotoxicity: a review

Soluble suppression of tumorigenicity-2 changes during cardiotoxic cancer treatment: a systematic review and meta-analysis

Case Report: Diagnostic challenges and therapeutic approaches in cardiac intimal sarcoma: a rare clinical case study

Current strategies for prevention of cancer therapy-related cardiotoxicity: pharmacological, non-pharmacological and emerging approaches

Analysis of risk factors for major adverse cardiac events in patients with multiple myeloma

From bench to bedside: investigating SGLT2 inhibitors as a novel strategy against chemotherapy-induced cardiomyopathy

A case report of hepatocarcinoma-originated pericardial malignancy

L-shaped association of low-density lipoprotein cholesterol with all-cause and cardiovascular mortality in cancer survivors: a population-based cohort study

SGLT2i use is associated with reduced risks of cardiopulmonary inflammatory complications in cancer patients with diabetes: a retrospective cohort study